NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2021 – Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards Clinical Trials
SHELTON, CT / ACCESSWIRE / November 16, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”)…
Fab-Form Industries Ltd. Announces Results for the Quarter Ended 30 September 2025
Aires Announces Record Q3/2025 Revenue of $7.4 Million and 61% YoY Sales Growth and Discusses Factors Related to Liquidity and Continuing Operations
MyndTec Inc. Announces Resignation of Director
Syntheia Announces Closing of Shares for Debt Transaction
Eddy Smart Home Solutions Ltd. Announces Q3/2025 Financial Results